🇺🇸 FDA
Patent

US 11389550

Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound

granted A61KA61K2123/00A61K49/06

Quick answer

US patent 11389550 (Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound) held by NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY
Grant date
Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2123/00, A61K49/06, A61K49/10, A61K49/1824